PD-1 blockade: a therapeutic option for treatment of metastatic Merkel cell carcinoma

The immune system is extremely important in the development and progression of Merkel cell carcinoma (MCC). Immune checkpoint blockade has recently been shown to enable efficacious treatment of a variety of tumours. We report the use of an anti-programmed death receptor 1 (PD-1) antibody for treatme...

Full description

Saved in:
Bibliographic Details
Main Authors: Winkler, Julia K. (Author) , Bender, Carolin (Author) , Kratochwil, Clemens (Author) , Enk, Alexander (Author) , Hassel, Jessica C. (Author)
Format: Article (Journal)
Language:English
Published: 2017
In: British journal of dermatology
Year: 2016, Volume: 176, Issue: 1, Pages: 216-219
ISSN:1365-2133
DOI:10.1111/bjd.14632
Online Access:Verlag, Volltext: http://dx.doi.org/10.1111/bjd.14632
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjd.14632
Get full text
Author Notes:J.K. Winkler, C. Bender, C. Kratochwil, A. Enk and J.C. Hassel

MARC

LEADER 00000caa a2200000 c 4500
001 1577410815
003 DE-627
005 20230426230618.0
007 cr uuu---uuuuu
008 180709r20172016xx |||||o 00| ||eng c
024 7 |a 10.1111/bjd.14632  |2 doi 
035 |a (DE-627)1577410815 
035 |a (DE-576)507410815 
035 |a (DE-599)BSZ507410815 
035 |a (OCoLC)1341013388 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Winkler, Julia K.  |d 1987-  |e VerfasserIn  |0 (DE-588)1038218993  |0 (DE-627)756780721  |0 (DE-576)392196514  |4 aut 
245 1 0 |a PD-1 blockade  |b a therapeutic option for treatment of metastatic Merkel cell carcinoma  |c J.K. Winkler, C. Bender, C. Kratochwil, A. Enk and J.C. Hassel 
264 1 |c 2017 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First published: 01 April 2016 
500 |a Gesehen am 09.07.2018 
520 |a The immune system is extremely important in the development and progression of Merkel cell carcinoma (MCC). Immune checkpoint blockade has recently been shown to enable efficacious treatment of a variety of tumours. We report the use of an anti-programmed death receptor 1 (PD-1) antibody for treatment of a patient with metastatic MCC. An 80-year-old patient with metastatic MCC received off-label treatment with the anti-PD-1 antibody pembrolizumab after the disease had progressed during therapy with oral etoposide. A positron emission tomography (PET) computed tomography scan performed after three cycles of pembrolizumab revealed responses to therapy with reduced size of the adrenal gland metastases and less PET activity in the adrenal gland and lymph node metastases. Treatment was resumed owing to disease progression after a treatment-free interval of > 4 months. During subsequent months of treatment, the size of the metastases stabilized and uptake of nuclide by all tumour sites once again decreased. These results reveal the potential efficacy of an anti-PD-1 antibody for treatment of metastatic MCC. Thus, they contribute to currently limited data on the use of anti-PD-1 antibodies for the treatment of MCC. Moreover, this is the first report of successful resumption of treatment of metastatic MCC with an anti-PD-1 antibody. Results from ongoing trials will contribute to determination of the relevance of PD-1 blockade in metastatic MCC. 
534 |c 2016 
700 1 |a Bender, Carolin  |d 1986-  |e VerfasserIn  |0 (DE-588)104603121X  |0 (DE-627)775247642  |0 (DE-576)399340041  |4 aut 
700 1 |a Kratochwil, Clemens  |d 1978-  |e VerfasserIn  |0 (DE-588)134026276  |0 (DE-627)559871686  |0 (DE-576)300262787  |4 aut 
700 1 |a Enk, Alexander  |d 1963-  |e VerfasserIn  |0 (DE-588)1032757140  |0 (DE-627)739272535  |0 (DE-576)166173517  |4 aut 
700 1 |a Hassel, Jessica C.  |d 1975-  |e VerfasserIn  |0 (DE-588)129790702  |0 (DE-627)480399069  |0 (DE-576)29783715X  |4 aut 
773 0 8 |i Enthalten in  |t British journal of dermatology  |d Oxford : Oxford University Press, 1951  |g 176(2017), 1, Seite 216-219  |h Online-Ressource  |w (DE-627)320433803  |w (DE-600)2004086-6  |w (DE-576)091140285  |x 1365-2133  |7 nnas  |a PD-1 blockade a therapeutic option for treatment of metastatic Merkel cell carcinoma 
773 1 8 |g volume:176  |g year:2017  |g number:1  |g pages:216-219  |g extent:4  |a PD-1 blockade a therapeutic option for treatment of metastatic Merkel cell carcinoma 
856 4 0 |u http://dx.doi.org/10.1111/bjd.14632  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bjd.14632  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180709 
993 |a Article 
994 |a 2017 
998 |g 129790702  |a Hassel, Jessica C.  |m 129790702:Hassel, Jessica C.  |d 910000  |d 911300  |e 910000PH129790702  |e 911300PH129790702  |k 0/910000/  |k 1/910000/911300/  |p 5  |y j 
998 |g 1032757140  |a Enk, Alexander  |m 1032757140:Enk, Alexander  |d 910000  |d 911300  |e 910000PE1032757140  |e 911300PE1032757140  |k 0/910000/  |k 1/910000/911300/  |p 4 
998 |g 134026276  |a Kratochwil, Clemens  |m 134026276:Kratochwil, Clemens  |d 910000  |d 911400  |e 910000PK134026276  |e 911400PK134026276  |k 0/910000/  |k 1/910000/911400/  |p 3 
998 |g 104603121X  |a Bender, Carolin  |m 104603121X:Bender, Carolin  |d 910000  |e 910000PB104603121X  |k 0/910000/  |p 2 
998 |g 1038218993  |a Winkler, Julia K.  |m 1038218993:Winkler, Julia K.  |d 910000  |d 911300  |e 910000PW1038218993  |e 911300PW1038218993  |k 0/910000/  |k 1/910000/911300/  |p 1  |x j 
999 |a KXP-PPN1577410815  |e 3016669935 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1577410815"],"doi":["10.1111/bjd.14632"]},"name":{"displayForm":["J.K. Winkler, C. Bender, C. Kratochwil, A. Enk and J.C. Hassel"]},"recId":"1577410815","physDesc":[{"extent":"4 S."}],"title":[{"subtitle":"a therapeutic option for treatment of metastatic Merkel cell carcinoma","title":"PD-1 blockade","title_sort":"PD-1 blockade"}],"note":["First published: 01 April 2016","Gesehen am 09.07.2018"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"320433803","disp":"PD-1 blockade a therapeutic option for treatment of metastatic Merkel cell carcinomaBritish journal of dermatology","origin":[{"publisher":"Oxford University Press ; Blackwell Science ; Blackwell ; Wiley-Blackwell","dateIssuedKey":"1951","dateIssuedDisp":"1951-","publisherPlace":"Oxford ; Oxford [u.a.] ; Oxford [u.a.] ; Oxford"}],"note":["Gesehen am 03.07.25"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"subtitle":"BJD ; the journal of the British Association of Dermatologists","title":"British journal of dermatology","title_sort":"British journal of dermatology"}],"corporate":[{"display":"British Association of Dermatologists","role":"isb"}],"titleAlt":[{"title":"BJD"}],"pubHistory":["Volume 63, issue 1 (January 1951)-"],"part":{"volume":"176","year":"2017","extent":"4","text":"176(2017), 1, Seite 216-219","issue":"1","pages":"216-219"},"id":{"doi":["10.1111/(ISSN)1365-2133"],"zdb":["2004086-6"],"eki":["320433803"],"issn":["1365-2133"]}}],"person":[{"display":"Winkler, Julia K.","role":"aut","given":"Julia K.","family":"Winkler"},{"display":"Bender, Carolin","family":"Bender","role":"aut","given":"Carolin"},{"family":"Kratochwil","given":"Clemens","role":"aut","display":"Kratochwil, Clemens"},{"display":"Enk, Alexander","role":"aut","given":"Alexander","family":"Enk"},{"role":"aut","given":"Jessica C.","family":"Hassel","display":"Hassel, Jessica C."}],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"2017"}]} 
SRT |a WINKLERJULPD1BLOCKAD2017